Efficacy and Safety of Intranasal Fentanyl in the Treatment of Breakthrough Pain (FT-018-IM)

Update Il y a 4 ans
Reference: NCT00362583

Woman and Man

  • | Country :
  • Denmark
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Primary objectives: - To confirm the efficacy of intranasal fentanyl titrated to doses 50, 100 or 200 µg for treatment of breakthrough pain (BTP) in cancer patients - To establish long-term safety of treatment with intranasal fentanyl Secondary objectives: - To explore the relationship between dose of background opioid treatment and titrated fentanyl dose


Inclusion criteria

  • Cancer

Links